Pulse Biosciences Appoints New CEO, Dr. Darrin Uecker

Ticker: PLSE · Form: 8-K · Filed: Jul 14, 2025 · CIK: 1625101

Pulse Biosciences, Inc. 8-K Filing Summary
FieldDetail
CompanyPulse Biosciences, Inc. (PLSE)
Form Type8-K
Filed DateJul 14, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: leadership-change, executive-appointment, board-of-directors

TL;DR

New CEO at Pulse Biosciences! Dr. Uecker takes the helm, Trulock out.

AI Summary

Pulse Biosciences, Inc. announced on July 14, 2025, the appointment of Dr. Darrin Uecker as Chief Executive Officer, effective immediately. Dr. Uecker, who previously served as President and Chief Scientific Officer, will also join the company's Board of Directors. The company also announced the departure of Kevin L. Trulock as CEO and from the Board.

Why It Matters

This leadership change could signal a new strategic direction for Pulse Biosciences, potentially impacting its product development and market positioning in the medical device sector.

Risk Assessment

Risk Level: medium — Leadership changes can introduce uncertainty regarding future strategy and execution, impacting investor confidence.

Key Players & Entities

  • Pulse Biosciences, Inc. (company) — The company filing the report.
  • Dr. Darrin Uecker (person) — Newly appointed Chief Executive Officer and Board member.
  • Kevin L. Trulock (person) — Departing Chief Executive Officer and Board member.
  • July 14, 2025 (date) — Effective date of the CEO appointment and departure.

FAQ

Who has been appointed as the new CEO of Pulse Biosciences?

Dr. Darrin Uecker has been appointed as the new Chief Executive Officer of Pulse Biosciences.

When was the appointment of the new CEO effective?

The appointment of Dr. Darrin Uecker as CEO was effective immediately as of July 14, 2025.

Who previously held the CEO position at Pulse Biosciences?

Kevin L. Trulock previously held the CEO position at Pulse Biosciences.

What other roles will Dr. Darrin Uecker assume?

Dr. Darrin Uecker will also join the company's Board of Directors.

Did Kevin L. Trulock also depart from the Board of Directors?

Yes, Kevin L. Trulock departed from the Board of Directors.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on July 14, 2025 by Dr. Darrin Uecker regarding PULSE BIOSCIENCES, INC. (PLSE).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.